Testing blood and body markers in lung and chest cancers
Part of Cancer, Lungs & breathing clinical trials.
This study looks at “biomarkers,” which are measurable signs in the body (often in blood or samples), in people with lung or other chest cancers. It may help researchers better understand these cancers and improve how they’re diagnosed or tracked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a known or likely cancer in the chest (like the lungs) that needs a biopsy or surgical removal
- Be able to undergo surgery for the biopsy or excision
- Not have diabetes that is poorly controlled (your diabetes must be well managed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new “epigenetic” signals in blood (signals about how genes are turned on/off) to help detect lung cancer early. You might be able to join if you are being evaluated for possible lung cancer or have small, unclear spots on a lung CT scan.
This study is testing whether certain markers in your blood or tissue can help find lung cancer early. It is for people who have lung cancer that can be removed by surgery and haven't had treatment yet.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
This study looks at whether combining lung images with a blood test (DNA methylation) can help find lung cancer early. It is for people who have a new diagnosis of lung cancer and have not had treatment yet, as well as for people without cancer as a comparison.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
This study looks for specific genetic markers of lung cancer by testing tissue taken from a lung mass. It may help doctors detect and better understand lung cancer based on genetic clues.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.